Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 175.60
+0.30 (0.17%)
Sep 23, 2026, 4:08 PM HKT
HKG:2637 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, HKG:2637 stock has a consensus rating of "Strong Buy" and an average price target of $292.39. The average 1-year stock price forecast is 66.51% higher than the current stock price, while the lowest is $280.27 (+59.61%) and the highest is $304.50 (+73.41%).
Price Target: $292.39 (+66.51%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:2637 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| CMB International Securities | CMB International Securities | Buy Maintains $280.00 | Buy | Maintains | $280.00 | +59.45% | Sep 19, 2026 |
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $266.80 | Buy | Maintains | $266.80 | +51.94% | Sep 9, 2026 |
Unknown Analyst Guohai Securities No rating | Guohai Securities | Buy Maintains $339.55 | Buy | Maintains | $339.55 | +93.37% | Sep 1, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $298.99 | Buy | Maintains | $298.99 | +70.27% | Jul 3, 2026 |
Unknown Analyst Huafu Securities No rating | Huafu Securities | Buy Maintains $264.30 | Buy | Maintains | $264.30 | +50.51% | Jun 14, 2026 |
Financial Forecast
Revenue This Year
702.50M
from 582.36M
Increased by 20.63%
Revenue Next Year
813.50M
from 702.50M
Increased by 15.80%
EPS This Year
2.46
EPS Next Year
2.80
from 2.46
Increased by 14.05%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.